Websites could go dark

Plus, what comes next for Ukraine?

Go beyond the headlines with Reuters on the stories shaping the day. Subscribe for $1/week. Daily Briefing Daily Briefing By Kate Turton Hello. Our top story is Putin hosting Trump's envoy for new Ukraine peace talks. Elsewhere, our readers are clicking on news of beauty giants targeting "Ozempic face" and a cyber agency warning that websites may go dark. In yesterday's Daily Briefing, we launched a new series on "the age of heat storms." Let us know: how have extreme weather events shaped your year? Share your experience with our journalists using this form. Today's Top News   Russian presidential envoy Kirill Dmitriev greets US special envoy Steve Witkoff upon his arrival at Pulkovo Airport in Saint Petersburg. Obtained by Reuters/Handout via REUTERS Ukraine and Russia at War President Vladimir Putin hosted US Special Envoy Steve Witkoff in a grand imperial palace to review new ideas on ending the war in Ukraine. The encounter comes amid concerns in Kyiv and among its allies that the United States is backing away from Ukraine US Secretary ‌of State Marco Rubio said that decisions regarding Ukraine's access to Starlink were up to SpaceX and Elon Musk, not the White House, comments that suggested Musk may have restricted Kyiv's access to the service. Russia ‌will dispatch its first tanker with diesel for the US on Thursday, Deputy Prime Minister Alexander Novak said, according to the Vedomosti news outlet, after a deal with President Donald Trump. In other news The developers of the widely used PHP programming language said they would release patches for two critical vulnerabilities, as EU cybersecurity officials warned organisations unable to apply the fixes should take affected websites offline. President Trump's administration has revoked over 300,000 US visas during his second term, the State Department said as the federal government continues its sweeping immigration crackdown. A Democrat is running neck and neck for a US Senate seat in a state that hasn't elected one in 94 years. Renee Hickman is on the Reuters World News podcast to explain the two issues which are front of mind for Kansas voters. Britain approved the Jackdaw North ‌Sea gas field, ending years of legal and political wrangling that had pitted the Labour government's climate commitments against its push to bolster energy security. France will reinforce police with troops and mount a huge security operation for more protests planned on Saturday, the government said, acknowledging failures in its response to last weekend's violence. Nigeria reported its first Ebola case in more than a decade, becoming the fourth African country and the most populous yet to be affected by an outbreak that health officials have described as the fastest-spreading on record. Business & Markets   Jio Platforms' $3.2 billion IPO was fully subscribed in less than two hours of public bidding, ‌as investors flocked to India's largest share sale and the first from billionaire Mukesh Ambani's Reliance in two decades. Anthropic's net loss widened sharply to $80.7 billion in the first half of this year, in large part due to a rise in the fair value of bonds convertible into shares of the ‌AI startup, according to a draft prospectus for a planned initial public offering that was reviewed by Reuters. Elon Musk said that a merger of his two companies SpaceX  and Tesla would be "a good idea" and that they had formed special committees to discuss a union, sending shares of the space and technology company up 8% in extended trading. Here's all you need to know about the potential merger. The Trump administration is offering to loan up to nearly a third of the 1-million-barrel ‌US emergency heating oil reserve, the Department of Energy said, in a bid to tame prices, which have surged on diesel shortages. Read our exclusive. British inflation and borrowing rose more than expected last month, according to data that will add to calls for help ‌for households in finance minister John Healey's first budget next week and the likelihood of a Bank of England interest rate hike. Beauty giants target 'Ozempic face' as boom in obesity drugs opens new market   A patient receives a Sculptra injectable in Miami. Galderma/Handout via REUTERS/ File Photo Swiss skincare firm Galderma, Brazilian cosmetics group Natura, and beauty giant L'Oreal are testing treatments for consumers worried about facial sagging and volume loss, looking to capitalise on a growing market tied to the boom in obesity drugs. The ‌companies are targeting concerns known as "Ozempic face," a term that emerged as the diabetes drug became widely associated with weight loss. Experts say the loss of facial volume is linked to rapid weight loss rather than GLP-1 drugs themselves. This is the third story in a five-part Reuters series on how weight-loss drugs are changing the way people shop and eat, and how companies are responding to the trend. Read more And Finally... Britain's Prince Harry and Meghan, the Duke and Duchess of Sussex, greet well wishers in Nottingham. REUTERS/Phil Noble Prince Harry has said he hoped to reconcile with King Charles and the rest of his family with whom he fell out when he moved to the United States six years ‌ago. The king's younger son caused a rupture in the British royal family when he and his wife Meghan quit royal duties and moved to California in 2020 from where they were highly critical of the institution. But in an interview with GQ magazine, Harry, who recently relocated back to Britain with Meghan and their two children, said he wanted to patch ⁠things up. Read more   Sponsors are not involved in the creation of newsletters or other Reuters news content. Advertise in this newsletter or on Reuters' website   Reuters Daily Briefing is sent 5 days a week. Think your friend or colleague should know about us? Forward this newsletter to them. They can also sign up here. Want to stop receiving this email? Unsubscribe here. To manage which newsletters you're signed up for, click here. This email includes limited tracking for Reuters to understand whether you’ve engaged with its contents. For more information on how we process your personal information and your rights, please see our Privacy Statement. Terms & Conditions   © 2026 Thomson Reuters. All rights reserved. 3 Times Square, New York, NY 10036